SCHEMBL3631374

SCHEMBL3631374

Nc1nc(=O)c2nc(CBr)cnc2[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 3/20 0.40
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 3/20 0.37
HSD17B10 Q99714 3/20 0.37
LMNA P02545 1/20 0.37
GLA P06280 1/20 0.37
PMP22 Q01453 1/20 0.37
CCR1 P32246 1/20 0.32
MEN1 O00255 2/20 0.31
HPGD P15428 2/20 0.31
KMT2A Q03164 2/20 0.31
BACE1 P56817 1/20 0.31
MAPT P10636 1/20 0.31
THRB P10828 1/20 0.31
AKR1B1 P15121 3/20 0.31
TYMS P04818 1/20 0.30
POLB P06746 1/20 0.30
GAA P10253 1/20 0.30
TSHR P16473 1/20 0.30
PTGS2 P35354 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL3573044 0.98 NOS1 (0.39) NOS1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL14403234 0.86 NOS1 (0.40) NOS1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL6444231 0.84 NOS1 (0.40) NOS1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL1981722 0.84 ALDH1A1 (0.41) NOS1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL3528804 0.79 MAPK1 (0.41) NOS1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL22497884 0.76 ALDH1A1 (0.40) NOS1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL3526052 0.76 KDM4E (0.40) NOS1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL3528784 0.76 ALDH1A1 (0.40) NOS1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL853172 0.76 ALDH1A1 (0.40) NOS1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL9982658 0.75 NOS1 (0.68) NOS1KDM4EALDH1A1HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109553619-A A kind of preparation method of methotrexate (MTX) 北京斯利安药业有限公司 2019-04-02 CN claimed
CN-109553619-A A kind of preparation method of methotrexate (MTX) 北京斯利安药业有限公司 2019-04-02 CN disclosed
CN-109553619-A A kind of preparation method of methotrexate (MTX) 北京斯利安药业有限公司 2019-04-02 CN disclosed
EP-2150514-A2 18F-LABELLED FOLATES Merck Eprova AG (CH) 2010-02-10 EP disclosed
WO-2008125617-A2 18F-LABELLED FOLATES MERCK EPROVA AG (CH) 2008-10-23 WO disclosed